Lipid-regulating drugs
Cardiovascular System | BNF Section 0212
Items (National)
100.0M
NHS Cost
£205.6M
Substances
25
Drugs in Lipid-regulating drugs
| Drug | Items (National) | Cost | Practices |
|---|---|---|---|
| Atorvastatin | 73.2M | £87.9M | 7,528 |
| Simvastatin | 11.7M | £11.9M | 6,838 |
| Rosuvastatin calcium | 6.2M | £8.6M | 6,897 |
| Ezetimibe | 4.9M | £26.8M | 6,823 |
| Pravastatin sodium | 2.1M | £3.3M | 6,539 |
| Fenofibrate | 602.3K | £2.2M | 6,224 |
| Bempedoic acid/Ezetimibe | 323.2K | £19.2M | 5,292 |
| Bezafibrate | 296.4K | £2.1M | 5,502 |
| Colesevelam hydrochloride | 224.5K | £17.0M | 5,917 |
| Colestyramine | 171.7K | £4.4M | 5,960 |
| Bempedoic acid | 162.3K | £9.8M | 4,951 |
| Fluvastatin sodium | 81.4K | £545.4K | 3,520 |
| Omega-3-acid ethyl esters | 69.4K | £2.3M | 3,285 |
| Inclisiran | 41.2K | £2.0M | 3,273 |
| Icosapent | 30.7K | £4.1M | 1,619 |
| Ciprofibrate | 12.3K | £987.5K | 922 |
| Simvastatin and ezetimibe | 7,281 | £338.3K | 768 |
| Gemfibrozil | 5,001 | £155.5K | 495 |
| Evolocumab | 2,661 | £1.1M | 150 |
| Alirocumab | 1,563 | £624.3K | 96 |
| Acipimox | 1,001 | £39.0K | 112 |
| Colestipol hydrochloride | 187 | £100.0K | 55 |
| Ispaghula husk | 19 | £144 | 16 |
| Fenofibrate/simvastatin | 6 | £44 | 1 |
| Nicotinic acid | 1 | £61 | 1 |